Investigation of Patients Presenting With Acute Functional Neurological Symptoms

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age16+
SponsorUniversity Hospital, Basel, Switzerland

About this trial

Retrospective Single-center Analysis of Patients Presenting With Acute Neurological Symptoms, Aiming to Characterize the Frequency, Clinical Features, Diagnostic Pathways, and Healthcare Utilization of Patients with Functional Neurological Diseases

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Patients older than 16 years old presenting as an emergency case to the University Hospital Basel between 1 January 2012 and 31 March 2026

with acute neurological symptoms requiring immediate neurological work-up (e.g, acute motor or sensory disturbance, acute speech disorder, acute vestibular disorder, acute cognitive disorder, acute consciousness disorder, acute seizure disorder)

and a documented diagnostic evaluation during hospitalization.

Disqualifiers

Documented refusal for further use of health related data for research purposes

Insufficient documentation to determine diagnosis or clinical course

Incomplete or inconsistent datasets compromising valid endpoint determination

Younger than 16 years

Trial population

Patients presenting with acute symptoms

Trial design

Design model

Cohort

Time perspective

Retrospective

Treatments tested in this trial

  • collection of patient data

    Other intervention

    collection of patient data

Treatment groups

No treatment groups listed

Trial outcomes

Primary outcomes

1

Frequency of FND

The primary endpoint is the proportion of patients presenting with acute neurological symptoms who receive a diagnosis or likely differential diagnosis of Functional Neurological Disorder (FND) during their index hospital admission.

Time frame
At hospital discharge (index admission), up to 30 days from presentation

Secondary outcomes

1

Secondary Outcomes

Diagnostic Process Measures (%): Referral patterns and evaluation of alternative or concurrent neurological diagnoses.

Time frame
At hospital discharge (index admission), up to 30 days from presentation
2

Secondary Outcomes

Diagnostic Resource Utilization (%): Clinical examination findings, neuroimaging, neurophysiological testing, and laboratory investigations.

Time frame
At hospital discharge (index admission), up to 30 days from presentation
3

Secondary Outcomes

Healthcare Utilization and Outcomes (%): Discharge destination, readmission, outpatient follow-up, and in-hospital mortality.

Time frame
At hospital discharge (index admission), up to 30 days from presentation
4

Secondary Outcomes

Quality of Care Associations (%) Demographic and clinical variables associated with diagnostic performance and healthcare utilization.

Time frame
At hospital discharge (index admission), up to 30 days from presentation

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.